Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections

References

• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19.
   PubMed Web of Science ®Google Scholar
• WHO. Tracking SARS-CoV-2 variants. [cited 2002 Apr 1]. Available from: https://www.who.int/health-topics/nipah-virus-infection/tracking-SARS-CoV-2-variants
   Google Scholar
• Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022;602(7898):664–670.
   PubMed Web of Science ®Google Scholar
• Liu Y, Rocklöv J. The effective reproductive number of the omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med. 2022;29:taac037. DOI:10.1093/jtm/taac037. Epub ahead of print. PMID: 35262737; PMCID: PMC8992231.
   PubMed Web of Science ®Google Scholar
• Lyngse FP, Mortensen LH, Denwood MJ, et al. SARS-CoV-2 Omicron VOC transmission in Danish households. medRxiv 2021;2021.12.27.21268278. DOI:10.1101/2021.12.27.21268278
   Google Scholar
• Willett BJ, Grove J, MacLean OA, et al. The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism. medRxiv 2022;2022.01.03.21268111. DOI:10.1101/2022.01.03.21268111
   Google Scholar
• Bal A, Brengel-Pesce K, Gaymard A, et al. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021;11(1):14977.
   PubMed Web of Science ®Google Scholar
• Cevik M, Kuppalli K, Kindrachuk J, et al. Virology, transmission, and pathogenesis of SARS-CoV-2. Br Med J. 2020;371:m3862. DOI:10.1136/bmj.m3862
   PubMedGoogle Scholar
• van Kampen JJA, van de Vijver DAMC, Fraaij PLA, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12(1):267.
   PubMed Web of Science ®Google Scholar
• Jaafar R, Aherfi S, Wurtz N, et al. Correlation between 3790 quantitative polymerase chain reaction–positives samples and positive cell cultures, including 1941 severe acute respiratory syndrome coronavirus 2 isolates. Clin Infect Dis 2021;72(11):e921.
   PubMed Web of Science ®Google Scholar
• Hay JA, Kissler SM, Fauver JR, et al. Viral dynamics and duration of PCR positivity of the SARS-CoV-2 Omicron variant. medRxiv 2022.01.13.22269257. DOI:10.1101/2022.01.13.22269257
   Google Scholar
• Boucau J, Marino C, Regan J, et al. Duration of shedding of culturable virus in SARS-CoV-2 omicron (BA.1) infection. N Engl J Med 2022;387(3):275–277.
   PubMed Web of Science ®Google Scholar
• Puhach O, Adea K, Hulo N, et al. Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and Omicron. Nat Med. 2022;28:1491–1500. DOI:10.1038/s41591-022-01816-0
   PubMed Web of Science ®Google Scholar
• Coronavirus: circulation des variants du SARS-CoV-2. [cited 2022 May 9]. Available from: https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/coronavirus-circulation-des-variants-du-sars-cov-2
   Google Scholar
• Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance. [2021 Jan 28; cited 2022 July 11]. Available from: https://www.who.int/publications-detail-redirect/WHO-WPE-GIH-2021.1
   Google Scholar
• Bal A, Destras G, Gaymard A, et al. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020;26(7):960–962.
   PubMed Web of Science ®Google Scholar
• Bal A, Simon B, Destras G, et al. Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation, France, December 2021 - February 2022. medRxiv 2022.03.24.22272871. DOI:10.1101/2022.03.24.22272871
   Google Scholar
• Bal A, Pozzetto B, Trabaud M-A, et al. Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity, and association with virus neutralization test. Clin Chem. 2021;67(5):742–752.
   PubMed Web of Science ®Google Scholar
• Legros V, Denolly S, Vogrig M, et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol. 2021;18(2):318–327.
   PubMed Web of Science ®Google Scholar
• Mouton W, Compagnon C, Saker K, et al. Specific detection of memory T-cells in COVID-19 patients using standardized whole-blood interferon gammarelease assay. Eur J Immunol. 2021;51(12):3239–3242.
   PubMed Web of Science ®Google Scholar
• Trouillet-Assant S, Albert Vega C, Bal A, et al. Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study. BMJ Open. 2020;10(11):e041268.
   PubMed Web of Science ®Google Scholar
• Kissler SM, Fauver JR, Mack C, et al. Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons. N Engl J Med. 2021;385(26):2489–2491.
   PubMed Web of Science ®Google Scholar
• Jung J, Kim JY, Park H, et al. Transmission and infectious SARS-CoV-2 shedding kinetics in vaccinated and unvaccinated individuals. JAMA Netw Open. 2022;5(5):e2213606.
   PubMed Web of Science ®Google Scholar
• Khan K, Karim F, Cele S, et al. Omicron infection enhances Delta antibody immunity in vaccinated persons. Nature. 2022;607:356–359.
   PubMed Web of Science ®Google Scholar